Tailoring Antiplatelet Therapy in Acute Myocardial Infarction: When Is the ‘Bleeding Tax’ Justified?

Kyung Woo Park

Open source

DOI
10.4070/kcj.2026.0421
Published
2027
Container
Korean Circulation Journal
Publisher
XMLink
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4070/kcj.2026.0421,
  title = {Tailoring Antiplatelet Therapy in Acute Myocardial Infarction: When Is the ‘Bleeding Tax’ Justified?},
  author = {Kyung Woo Park},
  year = {2027},
  journal = {Korean Circulation Journal},
  doi = {10.4070/kcj.2026.0421},
  url = {https://doi.org/10.4070/kcj.2026.0421}
}

RIS

TY  - JOUR
TI  - Tailoring Antiplatelet Therapy in Acute Myocardial Infarction: When Is the ‘Bleeding Tax’ Justified?
AU  - Kyung Woo Park
PY  - 2027
JO  - Korean Circulation Journal
DO  - 10.4070/kcj.2026.0421
UR  - https://doi.org/10.4070/kcj.2026.0421
ER  - 

APA

Park, K. W. (2027). Tailoring Antiplatelet Therapy in Acute Myocardial Infarction: When Is the ‘Bleeding Tax’ Justified?. Korean Circulation Journal. https://doi.org/10.4070/kcj.2026.0421

Source records